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Abstract The human homologue of the canine GABA/betaine 
transporter (BGT-1) was isolated from a kidney inner medulla 
eDNA library. The coding sequence predicts a 614 amino acids 
protein with the typical features of neurotransmitter t ansporter 
family. The gene maps to chromosome 12p13 and, in addition to 
kidney, is also expressed in brain, liver, heart, skeletal muscle, 
and placenta. Functional studies reveal a K~ = 20 /tM for 
t ;ABA transport and a coupling to Na + and CI- with a stoichio- 
metry 3 Na+:2 CI-:I GABA. At 500/xM the GABA transport 
was inhibited by various compounds with the following potency 
order: quinidine > verapamil > phloretin > betaine. 
k(ey words: GABA; Betaine; Kidney; Transporter; Cell 
olume; Chromosomal localization 
I. Introduction 
Volume regulation is accomplished by several cell types 
l hrough active variations in the concentration of intracellular 
-olutes. In particular, epithelial cells from the renal inner me- 
dulla balance the extracellular hypertonicity by keeping a high 
ntracellular content of non-perturbing osmolytes like betaine, 
glycerophosphorylcholine, myo-inositol, sorbitol, and taurine 
[ 1]. Intracellular accumulation of some of these compounds up 
~o millimolar concentrations is performed by membrane trans- 
porters which use the favourable driving force for Na ÷ and CI-. 
Notably, molecular cloning of taurine and betaine transporters 
l rom kidney has revealed a strong sequence homology with a 
large superfamily of proteins involved in the uptake of neuro- 
!ransmitters [2]. These transporters are responsible for the ter- 
mination of synaptic transmission by lowering the level of the 
~eurotransmitter in the synaptic cleft. Interestingly, the canine 
i~etaine transporter (BGT-1) is also able to transport he inhib- 
itory neurotransmitter GABA with even higher affinity [3]. This 
, haracteristic would suggest hat GABA/betaine transporters 
itave a dual function in osmoregulation and synaptic transmis- 
,ion. 
Given the importance of these mechanisms to kidney physi- 
, ~logy and the possible involvement in human diseases, we un- 
dertook the identification of the human gene homologue of 
!3GT-1. In the present work we report the molecular cloning, 
unctional characterization, tissue distribution, and chromoso- 
~nal localization of a cDNA identified by screening a human 
:idney cDNA library with a BGT-1 probe. 
"~Corresponding author. Fax: (39) (10) 377 97 97. 
2. Materials and methods 
2.1 cDNA elon&g and sequencing 
A human cDNA library from the inner medulla of the kidney was 
constructed in the 2gt22 vector (BRL, Life Technologies) using NotI 
and Sail cloning sites. The library was screened with a PCR product 
obtained from human cDNA. To obtain this probe, different primer 
pairs were designed based on the dog BGT-1 sequence and tested. A 
1.5 kb amplification product was obtained with the following primers: 
forward, 5'-TTTCACAGCCACGTTTCC-Y, and reverse, 5'-CGTTC- 
AGTTGTCACTTCC-3', corresponding respectively to positions 720 
and 2269 in the BGT-I sequence [3]. PCR conditions were: 35 cycles, 
each of them composed by 1 min at 94°C, 1 min at 44°C, and 1 min 
30 s at 72°C, with a denaturing step at the beginning (3 min, 94°C) and 
an elongation step at the end (5 min, 72°C). This PCR product was 
cloned in a plasmid vector (TA cloning kit, Invitrogen) and sequenced 
using the Sequenase kit (U.S. Biochemicals). The sequence revealed 
strong homology with the canine GABA/betaine transporter. To screen 
the library, the amplification product was radiolabeled by random 
priming with [c~-32p]dCTP (Amersham). Phage DNA from positive 
clones was extracted with a commercially available kit (Qiagen). The 
DNA was Notl/Sail digested and Southern blots were performed with 
the PCR BGT-1 probe to analyze inserts. Largest positive cDNAs 
identified in this way were cloned in the pSPORTI vector (BRL) previ- 
ously cut with NotI and Sail. Recombinant transformations were veri- 
fied by digestion and PCR analysis performed with either SP6/T7 prim- 
ers and the specific primers reported above. A clone termed B18 showed 
an insert of about 3.4 kb whose nucleotide sequence was determined 
on both strands. 
2.2. Northern-blot analys& 
The cloned amplification product used for the screening of the library 
was radiolabeled and hybridized to a Northern-blot prepared with 2/zg 
of poly(A) ÷ RNA from multiple human tissues (human MTN blot, 
Clontech). Hybridization was carried out according to manufacturer's 
instruction. Filter was washed at high stringency with 2 × SSC, 0.05% 
SDS; then 2 × SSC, 0.1% SDS; I × SSC, 0.1% SDS; and finally 0.5 × 
SSC, 0.1% SDS. 
2.3. Chromosomal localization 
Chromosomal localization was obtained by fluorescent in situ hy- 
bridization on metaphase chromosomes prepared from a human lym- 
phoblastoid cell line by routine methods. Phage Agt22 DNA containing 
the B18 insert was labeled by nick translation (Boehringer) using biotin- 
16-dUTP. Signals were amplified twice and the slides were stained with 
propidium iodide and DAPI. 
2.4. eDNA transient expression 
To perform functional studies the B 18 cDNA clone, which represents 
the putative full-lenght coding sequence of the transporter, was excised 
from the pSPORT1 vector and cloned in the eukaryotic expression 
vector pcDNAI (Invitrogen) as a Pstl/NotI fragment. Transient expres- 
sion was achieved by electroporation f human tracheal 9HTEo- cells 
[4]. Briefly, the cells, detached by trypsinization, were washed in PBS, 
centrifuged, and resuspended in an ice-cold solution whose composition 
mimicked the intracellular environment [5]. Aliquots of 6.10 6 cells in 
0.7 ml of this solution were mixed with 20/lg of the recombinant 
pcDNAI plasmid or with the same amount of the plasmid without he 
insert as negative control. Cell/DNA suspensions were placed on ice for 
10 minutes and then electroporated with a Gene Pulser (Bio-Rad), using 
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a voltage pulse of 1.2 kV and a capacitance of 25/aF. After 10 minutes 
on ice, cells were diluted in culture medium (DMEM/FI2 plus 10% fetal 
calf serum) and plated in 24-well plates at a density of 3' 105 cells per 
well, Uptake experiments were carried out after 60 hours from electro- 
poration. 
2.5. GABA uptake 
Culture medium was removed and cells were washed with a solution 
containing (in mM): 130 NaC1, 2 KCI, 1 KH~PO4, 2 CaC12, 2 MgC12, 
10 Na-HEPES, 10 glucose, 20 mannitol (pH 7.3). Cells were then 
incubated with 1 ml of the same saline solution containing in addition 
0.5 pCi of [3H]GABA (specific activity 90 Ci/mmol, Amersham) and the 
appropriate amount of non radioactive GABA to obtain the desired 
concentration. Uptake was stopped by washing the cells three times 
with 1 ml of ice cold solution without GABA. Cells were then solubil- 
ized overnight in 0.5 ml of 0.25 M NaOH and 20/tl of cell lysate were 
used to determine the protein content of each well with a colorimetric 
assay (Bio-Rad). The remaining lysate was used to detect the radioac- 
tivity by liquid scintillation counting. Values of radioactivity incorpo- 
rated were converted in nanomoles of GABA per mg of protein. To 
evaluate he dependence of uptake on medium composition, Na ÷ or C1- 
were partially or totally replaced by equimolar amounts of N-methyl- 
~-glucamine or aspartate, respectively. 
3. Results 
Sequencing of B18, the largest clone obtained by screening 
of the human kidney cDNA library, showed an insert of 3433 
bp containing an open reading frame of 1842 bp which encodes 
a protein of 614 amino acids. This sequence has been deposited 
in GenBank with the accession umber U27699. Comparison 
of the coding sequence in our clone with that of a cDNA 
recently isolated from human brain [6] revealed only minor 
differences thus indicating that they arise from the same gene. 
In particular, three of these involve amino acid changes: 
R]0~Y~0, H571V572--~Q57]L57~. Thereason for these differences 
is not clear, but cannot be attributed to a sequence artifact. 
None of these substitutions seems to alter a known functional 
site. In addition, the B 18 clone extends 526 bp at the 5'-terminus 
and 990 bp at the 3'-terminus with respect o the sequence 
found by Borden et al. [6]. Browsing of sequence databases 
revealed a strong homology with the family of neurotransmitter 
transporter genes [2]. As shown in Fig. 1, there is a high amino 
acid sequence identity with the dog BGT-1 [3], the mouse 
GABA/betaine transporter GAT-2 [7], and GABA transporters 
GAT-3 and GAT-4 [8]. Hydropathy analysis according to the 
Kyte-Doolittle plot confirmed the typical features of neuro- 
transmitter t ansporters, i.e. 12 transmembrane stretches with 
a large extracellular loop between the third and the fourth 
transmembrane domains. A search for known consensus se- 
quences revealed three putative protein kinase C phosphoryla- 
tion sites in the cytosolic portion and two N-glycosilation sites 
in the large extracellular loop (Fig. 1). 
Northern blot analysis howed an interesting pattern of tis- 
sue distribution (Fig. 2). Two bands of 4.1 and 3.4 kb were 
observed in kidney, brain (where the former one was faint but 
Fig. 1. Deduced amino acid sequence of the human GABA/betaine 
transporter (hBGT-1) compared with the sequences of the correspond- 
ing canine transporter (dBGT-1), and murine GABA transporters 
(GAT-2, GATo3, GAT-4). Proposed transmembrane domains are un- 
derlined and numbered. Asterisks indicate amino acids identical in the 
five sequences. Triangles and crosses mark putative sites of N-linked 
glygosilation and PKC-mediated phosphorylation, respectively. 
clearly detectable with a longer exposition), and weakly in pla- 
centa. The 3.4 kb band was also expressed in liver whereas the 
4.1 kb band was present in heart and skeletal muscle. The last 
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I ig. 2. Tissue expression of hBGT-1 gene determined by Northern blot 
nalysis. Tissues are: 1, pancreas; 2, kidney; 3, skeletal muscle; 4, liver; 
:, lung; 6, placenta; 7, brain; 8, heart. 
~lssue also showed a 1.7 kb signal. No expression was instead 
.,Ipparent in lungs and pancreas. 
Chromosomal localization was carried out using the fluores- 
ent in situ hybridization technique. Hybridization signals were 
present in at least 80 human chromosomes in position 12p13 
,.nd were concordant in all the metaphases analysed. 
Expression of the B 18 clone in 9HTEo- cells caused a signif- 
icantly higher GABA uptake compared with the same cells 
, lectroporated with the vector alone. Preliminary experiments 
howed that the rate of GABA uptake was constant up to 
hour of incubation in both control and B18-expressing cells 
,Fig. 3). According to this, the uptake at 30 minutes was used 
"o calculate the kinetic parameters of GABA transport. Mock 
ransfected cells showed an uptake activity which displayed no 
aturat ion in the range 1-250 pM of GABA (Fig. 4A). This 
nrobably reflects the presence of an endogenous transporter 
15-  
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P~ig. 3. Time dependence ofGABA uptake in 9HTEo- cells transfected 
with the B18 cDNA clone (open symbols) or with the vector alone 
~filled symbols). GABA concentration was 100/zM (circles) or 10/JM 
~squares). Data are from a representative experiment. 
which is able to transport GABA with a very low affinity. On 
the contrary, cells transfected with the B18 clone displayed a
markedly higher uptake rate and saturation at high GABA 
concentrations. This was more evident after subtraction of 
the GABA transport activity measured in control cells 
from that measured in cDNA-transfected cells. Subtracted 
data showed saturation kinetics which could be well fitted 
with the Michaelis-Menten equation (Fig. 4A). Eadie-Hofstee 
analysis of 9 experiments performed in triplicate gave a 
K m = 20.4 + 1.6//M and a Vr~ax = 4.128 + 0.787 nmol/ mg 
(mean + S.E.M.; see Fig. 4B). 
Coupling of GABA uptake to Na ÷ and C1- was also investi- 
gated. Fig. 5 shows a representative experiment in which the 
endogenous component was subtracted from the total uptake 
in cDNA-transfected cells. As shown in Fig. 5, the relationship 
between GABA uptake rate and Na ÷ or C1- concentration was 
sigmoidal suggesting the movement of more than one ion for 
each molecule of GABA transported. To calculate the number 
n of ions involved, experimental data were fitted with the Hill- 
type equation: 
v = Vmax[X]'/(K o.5" + [X]') 
where v is the uptake rate, Ko,5 is the ion concentration allowing 
half-maximal ctivation, X is the ion coupled to GABA trans- 
port, and Vmax is the maximal uptake rate. The best values for 
n obtained from three separate xperiments perfomed in tripli- 
cate were 3.2 + 0.1 and 1.7 + 0.2 (mean + S.E.M.)for Na ÷ and 
CI-, respectively. 
~10- 
E 
C= 8-  
O 6-  
E 
~ 4- 
< 
m 
< 
~ 0 -  
A 
~6-  
.=- 5 - 
E 
o4-  
t~ 
~2-  
Q. 
0 .0  
O 
/ /  
1 I I [ 
50 100 150 200 
[GABA]  (pU) 
B 
Vmax=6.46 nmol /mg/30  min 
I I I I 
0,1 0.2 0,3 0.4 
Uptake/[GABA] (nmol/30 min/mg/p.M) 
& 
I 
250 
Fig. 4. Kinetics of GABA uptake. Data are from a representative 
experiment performed intriplicate. Standard errors are smaller than 5% 
of the corresponding mean value. (A) GABA uptake rate is plotted 
against the GABA concentration. Symbols are: open circles, hBGT-1 
cDNA-transfected cells; open squares, mock-transfected cells; filled 
circles, difference between former and latter data. (B) Eadie-Hofstee 
transformation f subtracted data from the same experiment. 
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lar GABA concentration was 1 #M. Data are from a representative 
experiment. Fitting of experimental points with a Hill-type equation 
gives a n of 3.3 and 1.7 for Na ÷ and CI-, respectively. 
To further characterize the transporter encoded by the B I8 
clone, different pharmacological gents were tested (Fig. 6). 
Betaine caused a dose dependent inhibition of GABA uptake 
with 500/IM being the concentration producing almost 50% of 
effect. At this same concentration quinidine, phloretin, and 
verapamil reduced the uptake by 94%, 64% and 69%, respec- 
tively. On the contrary, 500/.tM taurine did not significantly 
affect the transporter activity. The protein kinase C activator, 
phorbol 12-myristate 13-acetate (PMA), was also tested since 
the amino acid sequence contained putative protein kinase C 
phosphorylation sites. Preincubation of cells with PMA 1 and 
0.1/.zM for 10 minutes ignificantly inhibited GABA uptake by 
29% and 13%, respectively. 
A more detailed analysis was perfomed for betaine, vera- 
pamil, and quinidine to determine the type of inhibition. Fig. 
7 shows representative Eadie-Hofstee plots of GABA uptake 
in the absence and presence of 1 mM betaine, 500 ~tM vera- 
pamil, and 200/tM quinidine. In the presence of betaine, Km 
and Vmax were 62.9 + 17.1 /~M and 3.939 + 0.927 nmol/mg, 
respectively (mean + S.E.M., n = 3). The former value was 
significantly higher than in control conditions (P< 0.01), 
whereas the latter was not changed thus indicating that betaine 
acts as a pure competitive inhibitor. On the contrary, verapamil 
in 5 experiments behaved as a non-competitive inhibitor since 
it significantly owered Vm~x to 0.966 + 0.29 nmol/mg (P < 0.02) 
while leaving unchanged the K m (20.4 + 4,7 /tM). Quinidine 
instead showed mixed kinetics because it increased K~ to 
49.0 + 10.4/IM and lowered Vm~x to 2.276 + 0.499 nmol/mg 
(n = 3, P < 0.05 for both values). 
4. D iscuss ion  
Na+/C1--dependent monoamines and amino acids trans- 
porters constitute a rapidly developing area of interest and are 
characterized by a high degree of sequence homology [2]. Two 
subfamilies can be identified within this class of proteins: one 
is composed by the catecholamine transporters [9-11], whereas 
the other includes the amino acid-like transporters such as the 
choline and creatine transporters [12,13], GABA transporters 
[7,8,14], and the taurine transporter [15] which seems to resem- 
ble more closely the putative common ancestor for this subfam- 
ily [8]. Interestingly, the physiological role of GABA trans- 
porters (GATs) seems to be complicated by the fact that they 
can carry also other compounds uch as fl-alanine and taurine 
(mouse GAT-3 and GAT-4) [8], or betaine (mouse GAT-2) [7]. 
In particular, the high sequence identity between mouse GAT-2 
and dog BGT-1 and the similar pharmacological properties 
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Fig. 6. Residual GABA uptake following application of the indicated 
compounds (concentrations are given in/IM). Data represent the nor- 
malized net uptake in cDNA-transfected cells after removal of the 
endogenous component. Extracellular GABA concentration was 10 
/tM. Columns represent the mean of three independent experiments. 
Error bars indicate standard eviation. A significant difference with 
respect o control is indicated by asterisks: *P < 0.05; **P < 0.01; 
***P < 0.001 (Student's t-test). 
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s aggest that they are the same betaine/GABA transporter, 
which could therefore be involved either in the control of 
(IABAergic synaptic transmission and in osmoregulation, de- 
Fending on the site of expression. While preparing this manu- 
script, Borden et al. have identified the human homologue of 
BGT-1 and GAT-2 in brain striatum [6]. Our group has inde- 
l'endently cloned this gene (hBGT-1) starting from a different 
1 ssue, kidney inner medulla. In addition, we have extended the 
nowledge on hBGT-I by looking at the pattern ofgene expres- 
sion outside the brain, by determining kinetics parameters of 
/ }ABA transport and inhibitors, and by mapping the gene. 
Our results how that hBGT- 1 has a good affinity for GABA, 
,ith a Km of about 20/IM, significantly lower than that of 
t anine BGT-I [3] and mouse GAT-2 [7], higher than that of 
(}AT-1 and GAT-4 [8,14], and similar to that of mouse GAT-3 
Iq. The lack of commercially available radiolabeled betaine has 
t,recluded the possibility to study its transport in this work. 
Nevertheless, the competitive inhibition of GABA uptake by 
on-radioactive betaine (IC50=500 ¢tM) indicates that betaine 
i~ also transported but with an affinity at least one order of 
~ lagnitude lower than that for GABA. Activation of GABA 
ransport as a function of Na ÷ and C1- concentrations shows 
ooperativity with a probable stoichiometry of 3 Na + and 2 CI- 
ior each molecule of GABA transported. 
Pharmacological studies howed that hBGT-1 is inhibited by 
t,hloretin, and quinidine but not by taurine. Interestingly, and 
i a contrast with data presented by Borden et al. [6], quinidine 
was the most potent blocker. In addition, we discovered that 
x erapamil, a compound never tested before on neurotransmit- 
ter transporters, was also able to inhibit GABA uptake in a 
non-competitive fashion. It would be interesting to assess in 
future studies if it is also active on other members of this protein 
family. The activity of hBGT-1 was also reduced by incubation 
with the phorbol ester PMA though at relatively high concen- 
trations. Further studies are needed to evaluate the actual in- 
volvement of PKC in the inhibition of hBGT-I. 
The expression of hBGT-1 is quite widespread, having been 
found in kidney, brain, liver, heart, skeletal muscle and to a 
lesser extent in placenta. This pattern resembles that observed 
in mouse [7], whereas canine BGT-1 was found exclusively in 
kidney [3]. The physiological meaning of this kind of expression 
is not clear, and it is made more complex by the presence of at 
least hree transcription products which may arise from alterna- 
tive splicing. Being betaine plasma levels about two hundred 
times those of GABA (180 ¢tM vs. less than 1 /.tM), one 
should assume that GABA uptake function is restricted to the 
CNS. Outside the CNS, the major role for hBGT-1 could be 
the uptake of betaine to contrast a hyperosmotic extracellular 
medium. Nevertheless, prolonged hypertonic shocks are only 
experienced by kidney inner medulla during the concentration 
of urine. Therefore, the possibility of additional functions for 
this transporter cannot be ruled out and needs further investi- 
gation. 
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